巨仁堂品牌怎么样 申请店铺

我要投票 巨仁堂在连锁药店行业中的票数:89 更新时间:2025-01-05
巨仁堂是哪个国家的品牌?吉林巨仁堂药业股份有限公司,座落在药材宝库长白山南麓、浑江之畔、风景秀丽的通化市。公司始建于1975年,厂区占地面积4.5万平方米,建筑面积20000平方米,公司现有职工278人,营销人员1500多人
巨仁堂怎么样

吉林巨仁堂药业股份有限公司,座落在药材宝库长白山南麓、浑江之畔、风景秀丽的通化市。公司始建于1975年,厂区占地面积4.5万平方米,建筑面积20000平方米,公司现有职工278人,营销人员1500多人,营销网络遍布全国30个省,是一家集科研、生产、销售为一体的制药企业。她以技术力量强大,工艺设备先进,品种好又多,发展资金雄厚等优势,在医药舞台上发挥着越来越重要的作用。 

由于地处长白山,占有得天独厚的地理位置和资源优势,其产品采用长白山天然名贵药材精制而成,产品质量好,疗效高,深得广大患者信赖。公司总经理董起毓带领公司全体员工艰苦创业、诚信经营、以人为本、科技创新、开拓发展,通过创新企业管理机制、经营机制,开拓市场,开发新产品,大胆聘用制药人才,与科研部门合作,从而带出了一支有凝聚力的高素质企业队伍。  

2002年,企业筹集资金14500万元,进行GMP改造,2004年1月顺利通过达标验收,建成颗粒剂、丸剂、胶囊剂三个剂型的大型现代化制药企业,使企业的整体形象、生产能力大为改观,企业迈上了快速发展的轨道。在企业不断发展壮大的形势下,企业经济效益逐年提高,由于销量上升过快,2004年企业又筹集资金13500多万元,对丸剂、水蜜丸、口服液、糖浆剂进行GMP改造,2004年12月27日顺利通过国家GMP认证。两期GMP改造的成功认证,使企业的生产设施和产品质量已经达到国内领先的高科技水平。  

目前,已上市的产品有10个系列,共计38个品种,为企业的长足发展奠定了基础。 

多年来,企业利用地理资源优势,以严格的企业管理,与时俱进的工作精神,不断开拓市场,开展企业文化,来鼓舞人,激励人,凝聚人。公司生产的巨焱消牌炎立消胶囊(出口名称:CLOVERY)已获得出口资质,即已获得美国FDA认证和加拿大DIN认证。  

为确保出口产品重金属含量合格,保证出口产品的质量和数量,目前公司正在建设绿色中药材GAP生产基地,公司引进了先进的生产提取设备,建设了现代化的标准出口生产车间。绿色中药材GAP生产基地项目投产后,可年产中药材545吨,可满足本企业的需求。 

多年来,企业利用地理资源优势,以严格的企业管理,与时俱进的工作精神,不断开拓市场,增强效益。并获得了“纳税大户”、“重合同守信用企业”、“先进企业”、“重点保护单位”、“高新技术企业”等荣誉称号。巨仁堂药业正以稳健的脚步,踏上快速发展的轨道,去迎接并战胜更大的挑战。


Jilin jurentang Pharmaceutical Co., Ltd. is located in Tonghua City, which is located at the south foot of Changbai Mountain, Hunjiang River and has beautiful scenery. Founded in 1975, the company covers an area of 45000 square meters and a building area of 20000 square meters. The company has 278 employees and more than 1500 marketing personnel. Its marketing network covers 30 provinces in China. It is a pharmaceutical enterprise integrating scientific research, production and sales. She plays a more and more important role in the pharmaceutical stage with the advantages of strong technical force, advanced technology and equipment, good variety and abundant development funds. Because it is located in Changbai Mountain, it has a unique geographical location and resource advantage. Its products are refined from Changbai Mountain's natural and precious medicinal materials, with good quality and high curative effect, which are trusted by the majority of patients. Dong Qiyu, general manager of the company, led all employees of the company to work hard, operate in good faith, put people first, innovate in science and technology, develop and develop. By innovating enterprise management mechanism and operation mechanism, the company opened up market, developed new products, boldly employed pharmaceutical talents, and cooperated with scientific research departments, thus bringing out a cohesive high-quality enterprise team. In 2002, the enterprise raised 14.5 million yuan to carry out GMP transformation. In January 2004, the enterprise successfully passed the standard acceptance and built a large-scale modern pharmaceutical enterprise with three dosage forms of granules, pills and capsules, which greatly improved the overall image and production capacity of the enterprise and put it on the track of rapid development. Under the situation of continuous development and growth of the enterprise, the economic benefit of the enterprise has been improved year by year. Due to the rapid increase of sales volume, the enterprise raised more than 135 million yuan in 2004 to carry out GMP transformation of pills, honey pills, oral liquid and syrup, and successfully passed the national GMP certification on December 27, 2004. The successful certification of two phases of GMP transformation has made the production facilities and product quality of the enterprise reach the leading high-tech level in China. At present, there are 10 series of products on the market, 38 varieties in total, which lays the foundation for the rapid development of the enterprise. Over the years, enterprises have been using the advantages of geographical resources, strict enterprise management, working spirit of keeping pace with the times, constantly opening up markets, developing corporate culture, to inspire, inspire and unite people. The juyanxiao brand Yanlixiao capsule (export name: clovery) produced by the company has obtained export qualification, i.e. FDA certification in the United States and din certification in Canada. In order to ensure that the heavy metal content of export products is qualified and the quality and quantity of export products are guaranteed, the company is currently building a gap production base for green Chinese herbal medicines. The company has introduced advanced production extraction equipment and built a modern standard export production workshop. After the production base project of green Chinese herbal medicine GAP is put into production, the annual output of Chinese herbal medicine can reach 545 tons, which can meet the needs of the enterprise. Over the years, the enterprise has made use of the advantages of geographical resources, with strict enterprise management and the working spirit of keeping pace with the times, to continuously open up the market and enhance efficiency. It has also won the honorary titles of "big tax payer", "enterprise abiding by contracts and keeping promises", "advanced enterprise", "key protection unit" and "high and new technology enterprise". Jurentang pharmaceutical industry is stepping on the track of rapid development with steady steps to meet and overcome greater challenges.

本文链接: https://brand.waitui.com/991856d39.html

千城特选小程序码

7×24h 快讯

普利制药:公司股票将被实施退市风险警示,股票1月6日起停牌一天

36氪获悉,普利制药发布公告,海南普利制药股份有限公司股票及其可转换公司债券于2025年1月6日(星期一)开市起停牌一天,于2025年1月7日(星期二)开市起复牌;公司股票自2025 年1月7日开市起被实施“退市风险警示”,公司股票简称:由“普利制药”变更为“*ST 普利”,实施退市风险警示后公司股票交易的日涨跌幅限制仍为20%。

2小时前

白羽鸡苗行情回暖,业内:中长期优质商品代鸡苗供应仍显稀缺

12月下旬以来,毛鸡价格处于低位,利润空间有限,叠加近期鸡病肆虐,养殖户对“跨年鸡”降温,纷纷退订鸡苗,导致鸡苗价格一路走低。有小型种禽负责人表示,原来预定的客户近一半退订。不过,益生股份等大厂负责人表示,鸡苗行情已有回暖迹象,短期鸡苗成交价格或继续上涨。多位业内人士对财联社记者表示,中长期优质商品代鸡苗供应仍显稀缺。(财联社)

2小时前

杠杆资金本周重仓股曝光,中信证券居首

Wind统计显示,本周四个交易日中,共有1346只个股获融资净买入,净买入金额在千万元以上的有401只,25只个股融资净买入额超1亿元。中信证券本周获融资净买入居首,净买入额为5.87亿元。中国平安、紫金矿业、寒武纪-U净买入居前,金额分别为4.76亿元、4.44亿元、2.64亿元;中芯国际、万丰奥威、中兴通讯遭净卖出额居前,金额分别为16.29亿元、8.26亿元、7.88亿元。(第一财经)

2小时前

进一步丰富场内债券ETF产品线,华夏信用债ETF基金即将发行

日前获批的华夏上证基准做市公司债ETF(简称:信用债ETF基金;代码:511200)将于1月7日正式发行,该产品将进一步丰富场内债券ETF产品线,为中低风险偏好的投资者提供更多差异化的场内投资工具。据介绍,信用债ETF基金(511200)适合于希望配置场内固定收益资产、追求相对稳健回报的中低风险偏好投资者。此外,T+0交易机制也适合交易性投资者将其作为场内高效交易工具,承载更丰富灵活的投资策略。(新浪财经)

2小时前

韩国五大整车厂商去年新能源汽车销量同比增长11.1%至45万辆

据韩联社,综合韩国五大整车厂商1月5日发布的销售业绩,去年全年韩国新能源汽车销量同比增长11.1%,为45万辆,创历史新高。新能源汽车包括混动汽车、电动汽车和氢燃料电池汽车(FCEV)。其中,混动汽车销量同比增长24.9%,为35.6万辆,创新高。其销量在新能源汽车总销量中占比达88%。电动汽车销量同比减少21.2%,为9.1万辆,跌破10万辆。氢燃料电池汽车销量同比大减36.4%,为2751辆。按品牌看,现代汽车和起亚的新能源汽车销量同比增长5.8%,为42.3万辆,史上首破40万辆大关。(界面)

2小时前

本页详细列出关于开心人的品牌信息,含品牌所属公司介绍,开心人所处行业的品牌地位及优势。
咨询